pharma&
Elmar Zagler is the Founder & Managing Director of pharma& and the Co-Founder of elva pharma. Elmar previously held the position of Head of Commercial and Financial Operations Europe at Merus Labs. Prior to that, Elmar was the Head of Finance MCO Eastern Central Europe at Takeda Pharmaceuticals and Senior Business Controller at Region DACH & CEE. Elmar also has experience in managerial roles at Nycomed, Pfizer, Wyeth Austria, and Danone. Elmar holds a Master of Business Administration from Heriot-Watt University and a Mag. in Business Administration from WU (Vienna University of Economics and Business).
pharma&
1 followers
pharmaand GmbH (pharma&), a privately owned global company, aspires to breathe new life into proven medicines through our agile and fully integrated business model, guaranteeing the enduring availability, dependability, and quality of essential drugs worldwide that patients and healthcare providers rely on. Whether a former blockbuster or niche medicine, we acquire the worldwide rights to specialty treatments to secure long-term access to established and essential medicines across various specialized therapy areas, doing whatever it takes to maintain and develop the value of these medicines for all who depend on them. We’ve acquired and integrated 11 medicines over the past five years, expanding our portfolio across a wide range of therapy areas, with an increasing focus on hematology and oncology treatments. Our unique, fully integrated model across pharma&’s subsidiaries, joint ventures, and partners enables us to provide our portfolio of medicines to eligible healthcare providers and patients worldwide, spanning the continuum of manufacturing, distribution, administration/access, and patient support.